Endo in a Bite
This podcast from EZ Endo Prep delivers concise, high yield endocrinology content to help you study smarter and practice with confidence. Each episode breaks down complex topics into manageable pieces, making it ideal for endocrinology fellows and practicing endocrinologists.
- Indexed episodes, last 90 days
- 11
- Latest publication
- Sep 14, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 1) (opens the original)
Read excerpt
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes , focusing on continuous glucose monitoring fundamentals, CGM data quality, time in range targets, and glycemic variability. Topics include CGM components and interstitial glucose measurement, key glucose thresholds, the 5-25-70-4-1 CGM targets, hypoglycemia prioritization, coefficient of variation, time in tight range, glucose management indicator, GMI and laboratory
GAD65, IAA, IA-2, And ZnT8: Islet Autoantibodies in Type 1 Diabetes (opens the original)
Read excerpt
In this episode, we review the major islet autoantibodies used in type 1 diabetes, focusing on GAD65 in adults, IAA in young children, IA-2 and progression risk, and ZnT8 for additional diagnostic sensitivity. Topics include antibody testing strategies, presymptomatic screening and staging, single versus multiple autoantibody positivity, type 1 diabetes stages, factors affecting antibody interpretation, and the role of C peptide in evaluating autoimmune diabetes.
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Selecting Glucose Lowering Therapy (opens the original)
Read excerpt
In this episode, we review the 2026 Consensus Statement algorithm for selecting glucose lowering therapy in adults with type 2 diabetes, focusing on cardiovascular, heart failure, kidney, liver, weight, hypoglycemia, adverse effect, and cost considerations. Topics include medication efficacy, cardiovascular and cardiorenal benefits, weight effects, MASLD and MASH, renal dosing, adverse effects, and individualized treatment selection.
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 3) (opens the original)
Read excerpt
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on the transition beyond basal insulin. Topics include recognizing overbasalization, initiating and titrating prandial insulin, basal bolus insulin therapy, hypoglycemia classification and treatment, glucagon prescribing, the role of CGM in identifying glucose patterns, premixed insulin therapy, and practical strategies for optimizing glycemic control while minimizing
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 2) (opens the original)
Read excerpt
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on basal insulin initiation and titration. Topics include selecting the initial basal insulin dose based on A1C, structured titration strategies, dose reduction for hypoglycemia, titration intervals for different basal insulin preparations, once weekly insulin icodec, recognition of overbasalization using glucose patterns and the BEAM score, and when to consider prand
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.